Brief: Reneo Pharmaceuticals Posts Q2 Loss Per Share $0.50
Aug 9 (Reuters) - Reneo Pharmaceuticals Inc RPHM.O :
* RENEO PHARMACEUTICALS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS
* Q2 LOSS PER SHARE $0.50
* Q2 EARNINGS PER SHARE VIEW $-0.58 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9f83Wm
Further company coverage: RPHM.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Onkure Therapeutics
See all newsBrief: Onkure Therapeutics Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Onkure Therapeutics Inc expected to post a loss of $1.46 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker